Kronbach T[au] - Search Results

Year	Number of Results
1982	1
1984	3
1985	2
1986	3
1987	2
1988	1
1989	3
1991	4
1992	1
1993	1
1996	1
1999	2
2000	2
2001	3
2002	1
2003	1
2010	1
2011	1
2012	1
2022	0

1

Analysis of the catalytic specificity of cytochrome P450 enzymes through site-directed mutagenesis.

Johnson EF, Kronbach T, Hsu MH. Johnson EF, et al. Among authors: kronbach t. FASEB J. 1992 Jan 6;6(2):700-5. doi: 10.1096/fasebj.6.2.1537459. FASEB J. 1992. PMID: 1537459 Review.

2

Novel triazines as potent and selective phosphodiesterase 10A inhibitors.

Malamas MS, Stange H, Schindler R, Lankau HJ, Grunwald C, Langen B, Egerland U, Hage T, Ni Y, Erdei J, Fan KY, Parris K, Marquis KL, Grauer S, Brennan J, Navarra R, Graf R, Harrison BL, Robichaud A, Kronbach T, Pangalos MN, Brandon NJ, Hoefgen N. Malamas MS, et al. Among authors: kronbach t. Bioorg Med Chem Lett. 2012 Sep 15;22(18):5876-84. doi: 10.1016/j.bmcl.2012.07.076. Epub 2012 Jul 31. Bioorg Med Chem Lett. 2012. PMID: 22902656

3

Highly potent, selective, and orally active phosphodiesterase 10A inhibitors.

Malamas MS, Ni Y, Erdei J, Stange H, Schindler R, Lankau HJ, Grunwald C, Fan KY, Parris K, Langen B, Egerland U, Hage T, Marquis KL, Grauer S, Brennan J, Navarra R, Graf R, Harrison BL, Robichaud A, Kronbach T, Pangalos MN, Hoefgen N, Brandon NJ. Malamas MS, et al. Among authors: kronbach t. J Med Chem. 2011 Nov 10;54(21):7621-38. doi: 10.1021/jm2009138. Epub 2011 Oct 11. J Med Chem. 2011. PMID: 21988093

4

Discovery of imidazo[1,5-a]pyrido[3,2-e]pyrazines as a new class of phosphodiesterase 10A inhibitiors.

Höfgen N, Stange H, Schindler R, Lankau HJ, Grunwald C, Langen B, Egerland U, Tremmel P, Pangalos MN, Marquis KL, Hage T, Harrison BL, Malamas MS, Brandon NJ, Kronbach T. Höfgen N, et al. Among authors: kronbach t. J Med Chem. 2010 Jun 10;53(11):4399-411. doi: 10.1021/jm1002793. J Med Chem. 2010. PMID: 20450197

5

New metabolic pathways of alpha-lipoic acid.

Schupke H, Hempel R, Peter G, Hermann R, Wessel K, Engel J, Kronbach T. Schupke H, et al. Among authors: kronbach t. Drug Metab Dispos. 2001 Jun;29(6):855-62. Drug Metab Dispos. 2001. PMID: 11353754

6

In vivo efficacy in airway disease models of N-(3,5-dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), a selective phosphodiesterase 4 inhibitor for inhaled administration.

Kuss H, Hoefgen N, Johanssen S, Kronbach T, Rundfeldt C. Kuss H, et al. Among authors: kronbach t. J Pharmacol Exp Ther. 2003 Oct;307(1):373-85. doi: 10.1124/jpet.103.053942. Epub 2003 Aug 27. J Pharmacol Exp Ther. 2003. PMID: 12944497

7

Metabolism of retigabine (D-23129), a novel anticonvulsant.

Hempel R, Schupke H, McNeilly PJ, Heinecke K, Kronbach C, Grunwald C, Zimmermann G, Griesinger C, Engel J, Kronbach T. Hempel R, et al. Among authors: kronbach t. Drug Metab Dispos. 1999 May;27(5):613-22. Drug Metab Dispos. 1999. PMID: 10220491

8

Retigabine N-glucuronidation and its potential role in enterohepatic circulation.

Hiller A, Nguyen N, Strassburg CP, Li Q, Jainta H, Pechstein B, Ruus P, Engel J, Tukey RH, Kronbach T. Hiller A, et al. Among authors: kronbach t. Drug Metab Dispos. 1999 May;27(5):605-12. Drug Metab Dispos. 1999. PMID: 10220490

9

Identification of inhibitor binding sites of the cAMP-specific phosphodiesterase 4.

Richter W, Unciuleac L, Hermsdorf T, Kronbach T, Dettmer D. Richter W, et al. Among authors: kronbach t. Cell Signal. 2001 Apr;13(4):287-97. doi: 10.1016/s0898-6568(01)00150-4. Cell Signal. 2001. PMID: 11306246

10

Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.

Kronbach T, Mathys D, Umeno M, Gonzalez FJ, Meyer UA. Kronbach T, et al. Mol Pharmacol. 1989 Jul;36(1):89-96. Mol Pharmacol. 1989. PMID: 2787473

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results